RhGM-CSF ( DrugBank: rhGm-CSF )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
229	肺胞蛋白症（自己免疫性又は先天性）	4

229. 肺胞蛋白症（自己免疫性又は先天性）

臨床試験数 : 44 / 薬物数 : 22 - (DrugBank : 7) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 14

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02840708 (ClinicalTrials.gov)	May 2016	13/7/2016	SK-1401 (rhGM-CSF Agent for Inhalation) GM-CSF Inhalation Pharmacokinetic Study	SK-1401 (rhGM-CSF Agent for Inhalation) GM-CSF Inhalation Pharmacokinetic Study	Pulmonary Alveolar Proteinosis, Autoimmune	Drug: Sargramostim	Niigata University Medical & Dental Hospital	NULL	Completed	20 Years	80 Years	All	14	Phase 1	Japan
2	NCT02702180 (ClinicalTrials.gov)	March 21, 2016	28/2/2016	Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis	A Randomised, Double-blind, Placebo-controlled Multicentre Clinical Trial of Inhaled Molgramostim in ...	Autoimmune Pulmonary Alveolar Proteinosis	Drug: Molgramostim;Drug: Placebo;Device: PARI eFlow nebulizer system	Savara Inc.	NULL	Completed	18 Years	N/A	All	139	Phase 2	United States;Australia;Denmark;France;Germany;Greece;Israel;Italy;Japan;Korea, Republic of;Netherla ...
3	NCT02468908 (ClinicalTrials.gov)	May 2015	3/6/2015	Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects	A Randomized, Double-Blind, Placebo-Controlled, Single-Centre, Single Ascending Dose and Multiple As ...	Pulmonary Alveolar Proteinosis;Bronchiectasis;Cystic Fibrosis;Acute Respiratory Distress Syndrome	Drug: Molgramostim;Drug: Placebo	Savara Inc.	Celerion	Completed	18 Years	55 Years	All	42	Phase 1	United Kingdom
4	NCT01983657 (ClinicalTrials.gov)	January 2012	7/11/2013	Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.	Study of Subcutaneous Injection of Low-dose Recombinant Granulocyte Macrophage-Colony Stimulating Fa ...	Pulmonary Alveolar Proteinosis	Drug: rhGM-CSF;Procedure: Whole Lung Lavage(WLL)	Shanghai Pulmonary Hospital, Shanghai, China	NULL	Recruiting	17 Years	80 Years	Both	40	Phase 2	China

First Previous1Next Last